scholarly journals Intellectual disability-associated mutations in the ceramide transport protein gene CERT1 lead to aberrant function and subcellular distribution

2021 ◽  
pp. 101338
Author(s):  
Norito Tamura ◽  
Shota Sakai ◽  
Loreto Martorell ◽  
Roser Colomé ◽  
Aya Mizuike ◽  
...  
1990 ◽  
Vol 18 (24) ◽  
pp. 7448-7448 ◽  
Author(s):  
Y. Isomura ◽  
Y. Matumoto ◽  
A. Murayama ◽  
M. Chatani ◽  
N. Inouye ◽  
...  

1998 ◽  
Vol 273 (42) ◽  
pp. 27420-27429 ◽  
Author(s):  
To Y. Hui ◽  
Brigitte I. Frohnert ◽  
Anne Johnston Smith ◽  
Jean E. Schaffer ◽  
David A. Bernlohr

2010 ◽  
Vol 97 (11) ◽  
pp. 971-979 ◽  
Author(s):  
Yasukazu Okada ◽  
Satoshi Miyazaki ◽  
Shigeyuki Koshikawa ◽  
Richard Cornette ◽  
Kiyoto Maekawa ◽  
...  

2011 ◽  
Vol 300 (3) ◽  
pp. G384-G393 ◽  
Author(s):  
Jo H. Choi ◽  
John W. Murray ◽  
Allan W. Wolkoff

Although perturbation of organic anion transport protein (oatp) cell surface expression can result in drug toxicity, little is known regarding mechanisms regulating its subcellular distribution. Many members of the oatp family, including oatp1a1, have a COOH-terminal PDZ consensus binding motif that interacts with PDZK1, while serines upstream of this site (S634 and S635) can be phosphorylated. Using oatp1a1 as a prototypical member of the oatp family, we prepared plasmids in which these serines were mutated to glutamic acid [E634E635 (oatp1a1EE), phosphomimetic] or alanine [A634A635 (oatp1a1AA), nonphosphorylatable]. Distribution of oatp1a1AA and oatp1a1EE was largely intracellular in transfected human embryonic kidney (HEK) 293T cells. Cotransfection with a plasmid encoding PDZK1 revealed that oatp1a1AA was now expressed largely on the cell surface, while oatp1a1EE remained intracellular. To quantify these changes, studies were performed in HuH7 cells stably transfected with these oatp1a1 plasmids. These cells endogenously express PDZK1. Surface biotinylation at 4°C followed by shift to 37°C showed that oatp1a1EE internalizes quickly compared with oatp1a1AA. To examine a physiological role for phosphorylation in oatp1a1 subcellular distribution, studies were performed in rat hepatocytes exposed to extracellular ATP, a condition that stimulates serine phosphorylation of oatp1a1 via activity of a purinergic receptor. Internalization of oatp1a1 under these conditions was rapid. Thus, although PDZK1 binding is required for optimal cell surface expression of oatp1a1, phosphorylation provides a mechanism for fast regulation of the distribution of oatp1a1 between the cell surface and intracellular vesicular pools. Identification of the proteins and motor molecules that mediate these trafficking events represents an important area for future study.


PLoS ONE ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. e0243980
Author(s):  
Hiroaki Murakami ◽  
Norito Tamura ◽  
Yumi Enomoto ◽  
Kentaro Shimasaki ◽  
Kenji Kurosawa ◽  
...  

Intellectual disability (ID) is a developmental disorder that includes both intellectual and adaptive functioning deficits in conceptual, social, and practical domains. Although evidence-based interventions for patients have long been desired, their progress has been hindered due to various determinants. One of these determinants is the complexity of the origins of ID. The ceramide transport protein (CERT) encoded by CERT1 mediates inter-organelle trafficking of ceramide for the synthesis of intracellular sphingomyelin. Utilizing whole exome sequencing analysis, we identified a novel CERT variant, which substitutes a serine at position 135 (S135) for a proline in a patient with severe ID. Biochemical analysis showed that S135 is essential for hyperphosphorylation of a serine-repeat motif of CERT, which is required for down-regulation of CERT activity. Amino acid replacements of S135 abnormally activated CERT and induced an intracellular punctate distribution pattern of this protein. These results identified specific ID-associated CERT1 mutations that induced gain-of-function effects on CERT activity. These findings provide a possible molecular basis for not only new diagnostics but also a conceivable pharmaceutical intervention for ID disorders caused by gain-of-function mutations in CERT1.


Sign in / Sign up

Export Citation Format

Share Document